Last updated 2026-07-20
- Acquired by Sun Pharmaceutical Industries Ltd., Jun 2024
Total raised
—
Stage
Acquired
Founded
1950
Headcount
514
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company founded in 1950 in Haifa, Israel. The company specializes in the research, development, manufacturing, and marketing of generic prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada, and Israel. Taro's product portfolio includes topical dermatological formulations (creams, ointments, gels, foams), as well as oral solids, liquids, capsules, and tablets for therapeutic areas such as dermatology, cardiovascular health, neuropsychiatry, and anti-inflammatory conditions. The company also manufactures its own active pharmaceutical ingredients (APIs).
Headcount over time
514 employees (2026-09) · 1 point
Offices
Haifa, Israel · HQ / main office
Show all offices (2 more)
- Hawthorne, United States
- Brampton, Canada
Q&A
- What is the current status of Taro Pharmaceutical Industries?
- Taro Pharmaceutical Industries was acquired by Sun Pharma in June 2024.
- Where is Taro Pharmaceutical Industries headquartered?
- Taro Pharmaceutical Industries is headquartered in Haifa, Israel.
- What is Taro Pharmaceutical Industries' primary focus?
- Taro Pharmaceutical Industries is a research-based international pharmaceutical company manufacturing topical dermatological products and developing solid drugs in cardiology and neurology.
- How many employees does Taro Pharmaceutical Industries have?
- Taro Pharmaceutical Industries has over 500 employees.
- What is Taro Pharmaceutical Industries' business model?
- Taro Pharmaceutical Industries operates on a B2B business model.
- Does Taro Pharmaceutical Industries hold any patents?
- Yes, Taro Pharmaceutical Industries holds 1 patent.
- Who is the current CEO of Taro Pharmaceutical Industries?
- Uday Baldota serves as the CEO of Taro Pharmaceutical Industries.
- What is the market capitalization of Taro Pharmaceutical Industries?
- Taro Pharmaceutical Industries has a market capitalization of $1,277,876,352 USD.
Team · 30
Uday Baldota
Chief Executive Officer
Michael Perfetto
Chief Commercial Officer
Hagai Reingold
VP Global Head Of Operation
Itzik Baruch
VP Of Technical Services
Mariana Bacalu
VP Quality Affairs
Yoel Shamir
VP Operations
Dilip Shantilal Shanghvi
Chairman of The Board
Abhay Gandhi
Vice Chairman
Dov Pekelman
Board Member
James Kedrowski
Board Member
Robert Benjamin Stein
Board Member
Sudhir Vrundavandas Valia
Board Member
Linda Ben Shoshan
Board Member
Linda Benshoshan
Board Member
Kalyanasundaram Kal Sundaram Subramanian
CEO / President
Elijah Woodrow
Chief Operations Officer
Mariano Balaguer
CFO
Ron Kolker
Chief Financial Officer, Senior Vice President
Rob Gronk
Senior Vice President
Sheila Curran
VP Sales Operations
Ed Moniz
VP of Sales, OTC/Store Brand
Jim McManimie
Vice President Managed Care Sales
Rakesh Mehta
Asst. Vice President, Tech. Serv. & QA
Mitchell Kahan
executive director, customer finance
James Finley
Executive Director, Information Technology
Walter Jenkins
Vice President Purchasing
Joe Mach
VP, Tax Counsel
John Francis
Vice President, OTC Sales & Marketing - North America
Ara Aprahamian
VP Sales and Marketing
Carlton Holmes
VP Marketing OTC
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsmanufacturinghealthcare-providerstopical-treatmentcardiovascularoral-drugspediatricsdrug-discoveryhospitalsdermatologyanti-inflammatorytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | taro.com |
|---|---|
| linkedin.com/company/13778 |
Identifiers & details
| Legal name | Taro Pharmaceutical Industries Ltd. |
|---|---|
| Founded | 1950 |
| Employees (exact) | 514 |
| Offices | Hawthorne; Brampton |
| Market cap | $1.3B |
| Status reason | Acquired by Sun Pharma on Jun, 2024 |
Acquisitions & public offerings
Acquired by Sun Pharmaceutical Industries Ltd. 2024-06
Radar intelligence
Patents
| EPO | 66 |
|---|
Web history (Wayback)
| Domain | taro.com |
|---|
Certificate / subdomain footprint
| Subdomains | 14 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 520022906 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1959-06-03 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), annual_report (1) |
| Registered address | הקיטור 14 חיפה |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-18 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-18 | דו~ח שנתי-עדכון מען דיגיטלי |